DanishNagdaMDMBA

PubMed

• 11 citations
  Leiomyosarcoma of the head and neck: A 17‐year single institution experience and review of the National Cancer Data Base
  Alan D. Workman, Douglas R. Farquhar, Robert M. Brody, Arjun K. Parasher, Ryan M. Carey, Michael T. Purkey, Danish A. Nagda, John S. Brooks, Lee Hartner, Jason A. Bran...> ;Head & Neck. 2018 Apr 1
• 43 citations
  A Novel Chitosan-Hydrogel-Based Nanoparticle Delivery System for Local Inner Ear Application
  Shayanne A. Lajud, Danish A. Nagda, Peter Qiao, Nobuaki Tanaka, Alyssa M. Civantos, Rende Gu, Zhiliang Cheng, Andrew Tsourkas, Bert W. O'Malley, Daqing Li> ;Otology & Neurotology. 2015 Feb 1
• 13 citations
  Dual disruption of DNA repair and telomere maintenance for the treatment of head and neck cancer.
  Shayanne A. Lajud, Danish A. Nagda, Taku Yamashita, Jun Zheng, Nobuaki Tanaka, Waleed M. Abuzeid, Alyssa M. Civantos, Orysia Bezpalko, Bert W. O'Malley, Daqing Li> ;Clinical Cancer Research. 2014 Dec 15
• 24 citations
  Biliverdin's regulation of reactive oxygen species signalling leads to potent inhibition of proliferative and angiogenic pathways in head and neck cancer.
  Jun Zheng, Danish A. Nagda, Shayanne A. Lajud, Sanjeev Kumar, Anas Mouchli, Orysia Bezpalko, Bert W. O'Malley, Daqing Li> ;British Journal of Cancer. 2014 Apr 15
• 34 citations
  A regulated delivery system for inner ear drug application.
  Shayanne A. Lajud, Zhao Han, Fang-Lu Chi, Rende Gu, Danish A. Nagda, Orysia Bezpalko, Samudra Sanyal, Andrés M. Bur, Ziying Han, Bert W. O'Malley, Daqing Li> ;Journal of Controlled Release. 2013 Mar 28
• Join now to see all

Abstracts/Posters

• Using PD-L1 to Induce Chemosensitization of Head and Neck Squamous Cell Carcinoma
  Szymanowski AR, Qiao P, Lajud SA, Nagda DA, Civantos A, O’Malley BW, Li D, AAO-HNSF Annual Meeting 2014, Orlando, FL, 9/22/2014
• A 15-year Experience With Leiomyosarcoma in the Head and Neck
  Farquhar D, Nagda DA, Workman A, Purkey M, Newman J, 5th IFHNOS World Congress, New York, NY, 7/26/2014
• Targeting PD-L1 sensitizes head and neck squamous cell carcinoma to cisplatin
  Qiao P, Lajud SA, Nagda DA, Tanaka N, Civantos A, O'Malley BW, Li D, AACR Annual Meeting 2014, San Diego, CA, 4/7/2014
• The Development of Nanoparticles for Targeted Head and Neck Cancer Detection with Molecular Imaging
  Mouchli A, Lajud SA, Nagda DA, Zheng J, O'Malley BW, Li D, AAO-HNSF Annual Meeting 2013, Vancouver, BC, Canada, 9/30/2013
• Inhibition of Novel Cetuximab Resistance Pathway Leads to Improved Outcomes in Head and Neck Cancer
  Nagda DA, Lajud SA, Kumar S, Qiao P, Zheng J, O'Malley BW, Li D, AAO-HNSF Annual Meeting 2013, Vancouver, BC, Canada, 9/29/2013
• A Novel Regulated Nanohydrogel Delivery System for Inner Ear Application
  Lajud SA, Nagda DA, Mouchli A, Qiao P, O'Malley BW, Li D, AAO-HNSF Annual Meeting 2013, Vancouver, BC, Canada, 9/29/2013
• The Mre11/Rad50/Nbs1 (MRN) complex: A critical mediator of chemoresistance and cancer stem cell progression in head and neck squamous cell carcinoma.
  Nagda DA, Lajud SA, Yamashita T, Kumar S, Zheng J, Qiao P, Bezpalko O, O'Malley BW, Li D, AACR Annual Meeting 2013, Washington, DC, 4/15/2013
• Biliverdin inhibits head and neck cancer cell growth via activation of retinoblastoma signaling pathway
  Zheng J, Nagda DA, Lajud SA, Kumar S, Mouchli A, Bezpalko O, O'Malley BW, Li D, AACR Annual Meeting 2013, Washington, DC, 4/5/2013
• Biliverdin inhibits head and neck cancer cell growth via activation of retinoblastoma signaling pathway
  Zheng J, Nagda DA, Lajud SA, Kumar S, Mouchli A, Bezpalko O, O'Malley BW, Li D, AACR Annual Meeting 2013, Washington, DC, 4/5/2013
• Join now to see all

Lectures

• Fibrodysplasia Ossificans Progressiva: multiorgan effects of the ACVR1 mutation 
  2010 STER Summer Student Symposium - 8/26/2010